Quality of life impairment after a diagnosis of Cushing’s syndrome
Open Access
- 29 June 2022
- journal article
- review article
- Published by Springer Nature in Pituitary
- Vol. 25 (5) , 768-771
Abstract
This brief review is devoted mainly to publications in the last 5 years dealing with health-related quality of life (QoL) after a diagnosis of endogenous hypercortisolism, due to pituitary-dependent Cushing’s disease (CD) or any other cause of Cushing syndrome (CS). Despite improvement after treatment, persistent physical morbidity, neurocognitive problems like worse executive capacity and memory as well as stress intolerance, depressive symptoms and more anxiety, lead to long-term impairment of QoL.Keywords
This publication has 17 references indexed in Scilit:
- The association between physical activity, sleep, and quality of life in patients in bio-chemical remission from Cushing’s syndromeQuality of Life Research, 2020
- Psychiatric and neurocognitive consequences of endogenous hypercortisolismJournal of Internal Medicine, 2020
- Thigh Muscle Fat Infiltration Is Associated With Impaired Physical Performance Despite Remission in Cushing’s SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2020
- Improvement but no normalization of quality of life and cognitive functioning after treatment for Cushing’s syndromeThe Journal of Clinical Endocrinology & Metabolism, 2019
- Hippocampal Volume, Cognitive Functions, Depression, Anxiety, and Quality of Life in Patients With Cushing SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2019
- Illustration of patient-reported outcome challenges and solutions in rare diseases: a systematic review in Cushing’s syndromeOrphanet Journal of Rare Diseases, 2018
- Support Needs of Patients with Cushing’s Disease and Cushing’s Syndrome: Results of a Survey Conducted in Germany and the USAInternational Journal of Endocrinology, 2018
- Worse Health‐Related Quality of Life at long‐term follow‐up in patients with Cushing's disease than patients with cortisol producing adenoma. Data from the ERCUSYNClinical Endocrinology, 2018
- Enhanced self-efficacy after a self-management programme in pituitary disease: a randomized controlled trialEuropean Journal of Endocrinology, 2017
- Psychiatric Symptoms in Patients with Cushing’s Syndrome: Prevalence, Diagnosis and ManagementDrugs, 2017